Valuation Ipsen London S.E.

Stocks

Market Closed - London S.E. 16:30:00 28/08/2026 BST			5-day change	1st Jan Change
163.55 ^EUR	-3.05%		-0.09%	+37.78%

08-21	Ipsen S.A. completed the acquisition of Kartos Therapeutics, Inc.	CI
08-21	Ipsen Wraps Up Purchase of US-based Kartos Therapeutics	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	13,373	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	36.88%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	12,135	11,073	10,263
Change	-	16.81%	12.22%	1.81%	2.28%	31.53%	-8.75%	-7.31%
P/E	10.4x	12.9x	14x	26.7x	22.4x	13.6x	13.9x	14x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.62x	2.22x	1.92x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	-6.24x	-23.26x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	2.94x	2.88x	2.76x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.67x	2.39x	2.12x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	6.41x	6.24x	5.73x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	7.33x	7.34x	6.87x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	9.41x	9.1x	8.35x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	10.6%	11%	12%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.535	1.532	1.655
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.94%	0.94%	1.01%
EPS ²	7.76	7.81	7.73	4.15	5.32	12.02	11.75	11.68
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	12.8%	13%	14.2%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,543	4,637	4,840
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	1,893	1,776	1,792
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,656	1,508	1,494
Net income ¹	646.6	647.5	647.2	347.3	444.5	1,011	985.4	981.3
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,238	-2,299	-3,109
Reference price ²	80.50	100.50	107.90	110.70	119.00	163.10	163.10	163.10
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	81,990	-	-
Announcement Date	11/02/22	09/02/23	08/02/24	13/02/25	12/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.48x	12.15x	24.63x	0.59%	1,047B
JOHNSON & JOHNSON	29.56x	-	-	2.02%	646B
ABBVIE INC.	32.95x	7.64x	15.89x	2.66%	451B
ROCHE HOLDING AG	20.28x	4.82x	11.94x	2.74%	355B
NOVARTIS AG	22.04x	5.68x	14.08x	2.82%	291B
ASTRAZENECA PLC	21.17x	4.34x	12.4x	2.03%	252B
AMGEN INC.	27.64x	7.13x	12.67x	2.31%	234B
NOVO NORDISK A/S	13.24x	4.76x	9.94x	3.83%	203B
GILEAD SCIENCES, INC.	-45.49x	6.56x	25.62x	2.21%	181B
Average	17.21x	6.64x	15.90x	2.36%	406.59B
Weighted average by Cap.	24.29x	8.11x	17.93x	1.95%